Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
作者信息
Vedin J A, Wilhelmsson C E, Werkö L
出版信息
Br Heart J. 1973 Dec;35(12):1285-92. doi: 10.1136/hrt.35.12.1285.
Abstract
摘要
相似文献
1
Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
Br Heart J. 1973 Dec;35(12):1285-92. doi: 10.1136/hrt.35.12.1285.
2
[Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
Lakartidningen. 1973 Aug 15;70(33):2817-20.
3
A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension.
Acta Med Scand Suppl. 1974;554:47-54. doi: 10.1111/j.0954-6820.1974.tb02513.x.
4
[Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
Ugeskr Laeger. 1973 Jul 2;135(27):1431-8.
5
Effect of alprenolol and alprenolol in combination with saluretics in hypertension.
Acta Med Scand Suppl. 1974;554:39-45. doi: 10.1111/j.0954-6820.1974.tb02512.x.
6
Comparison between alprenolol and propranolol as antihypertensive agents. A double-blind cross-over study.
Acta Med Scand. 1972 Nov;192(5):415-8. doi: 10.1111/j.0954-6820.1972.tb04839.x.
7
Alprenolol and propranolol in the treatment of hypertension: a comparative study.
Acta Med Scand Suppl. 1974;554:33-7. doi: 10.1111/j.0954-6820.1974.tb02511.x.
8
A within-patient comparison of alprenolol and propranolol in hypertension.
Acta Med Scand. 1973 Jun;193(6):547-50. doi: 10.1111/j.0954-6820.1973.tb10624.x.
9
Long-term effect of alprenolol as antihypertensive agent.
Acta Med Scand Suppl. 1974;554:9-14. doi: 10.1111/j.0954-6820.1974.tb02508.x.
10
Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
Br Heart J. 1973 Mar;35(3):320-33. doi: 10.1136/hrt.35.3.320.
引用本文的文献
1
Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.
Eur J Clin Pharmacol. 1976;10(6):375-9. doi: 10.1007/BF00563072.
2
Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
Eur J Clin Pharmacol. 1979;16(6):369-74. doi: 10.1007/BF00568195.
3
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.
Eur J Clin Pharmacol. 1977 Mar 11;11(3):159-62. doi: 10.1007/BF00606404.
4
Controlled study of atenolol in treatment of hypertension.
Br Med J. 1975 May 17;2(5967):367-70. doi: 10.1136/bmj.2.5967.367.
5
Haemodynamic effects of beta-adrenorecptor blockers in hypertension.
Drugs. 1976;11 SUPPL 1:127-34. doi: 10.2165/00003495-197600111-00028.
本文引用的文献
1
Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension.
Am J Cardiol. 1962 Jun;9:863-7. doi: 10.1016/0002-9149(62)90211-4.
2
Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.
Science. 1960 Jun 24;131(3417):1890-1. doi: 10.1126/science.131.3417.1890.
3
ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION.
Med Clin North Am. 1964 Mar;48:335-45. doi: 10.1016/s0025-7125(16)33467-8.
4
Methydopa for treatment of hypertension.
JAMA. 1963 May 25;184:616-21. doi: 10.1001/jama.1963.03700210050008.
5
Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
Circulation. 1962 Feb;25:281-91. doi: 10.1161/01.cir.25.2.281.
6
Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
Acta Pharmacol Toxicol (Copenh). 1967;25:9-40.
7
Effects of methyldopa in fifty hypertensive patients.
Clin Pharmacol Ther. 1967 Mar-Apr;8(2):224-34. doi: 10.1002/cpt196782224.
8
Propranolol in hypertension.
Am J Cardiol. 1966 Sep;18(3):387-93. doi: 10.1016/0002-9149(66)90059-2.
9
Treatment of hypertension with propranolol.
Br Med J. 1969 Jan 4;1(5635):7-16. doi: 10.1136/bmj.1.5635.7.
10
[Methyldopa in the therapy of hypertension].
Tidsskr Nor Laegeforen. 1968 Jul 15;88(14):1416-20.
Zotero 插件